SAFETY AND HEALTH POLICY CONSIDERATIONS RELATED TO THE USE OF BUPRENORPHINE/NALOXONE AS AN OFFICE-BASED TREATMENT FOR OPIATE DEPENDENCE

Gardado en:
BRIDGE, T.P., ET AL., SAFETY AND HEALTH POLICY CONSIDERATIONS RELATED TO THE USE OF BUPRENORPHINE/NALOXONE AS AN OFFICE-BASED TREATMENT FOR OPIATE DEPENDENCE. DRUG AND ALCOHOL DEPENDENCE, Vol. 70, no. 2 SUPL. (2003), p. S79-S85.
Ref. 121194
Localización: SIIS R.854 Archivo
Palabras clave:
Antagonistas, Buprenorfina, Crítica, Drogodependencias, Fármacos, Heroína, Programas de desintoxicación, Programas de mantenimiento, Seguridad, Servicios de salud